Kristina Drizyte-Miller
7PUBLICATIONS
75CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer.Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp
|Jul 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp
|Feb 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker
|Jun 06, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker
|Jun 06, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp
|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.Craig M Goodwin, Andrew M Waters, Jennifer E Klomp
Pageof 2
Frequent Collaborators
6 joint publications
Channing J Der
6 joint publications
Adrienne D Cox
6 joint publications
Kirsten L Bryant
6 joint publications
Clint A Stalnecker
4 joint publications
Emanuel F Petricoin
4 joint publications
Khalilah E Taylor
4 joint publications
Jennifer E Klomp
4 joint publications
Jeffrey A Klomp
4 joint publications
Elisa Baldelli
3 joint publications
Runying Yang
